
|Videos|June 24, 2022
Dr. Miller: “No limits” to what HoLEP can offer appropriate patients with BPH
Author(s)Urology Times staff
“We're doing probably one of the highest volume of HoLEP cases…in the United States,” says Nicole L. Miller, MD, FACS.
Advertisement
In this video, Nicole L. Miller, MD, FACS, discusses what sets her HoLEP practice for treating patients with benign prostatic hyperplasia from other centers. Miller is a professor of urology and fellowship director, Endourology and Laparoscopic Surgery, at Vanderbilt University Medical Center in Nashville, Tennessee.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5


















